Research classification: Human clinical research
Compound overview
Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone (GHRH), investigated in defined endocrine and metabolic clinical settings.
Published research
A 2014 randomized trial studied tesamorelin in adults with HIV-associated abdominal adiposity and assessed visceral and liver fat endpoints. Additional controlled studies examined related body-composition measures.
Evidence limitations
Studies of an approved or investigational pharmaceutical formulation do not establish the sterility, identity, dosage accuracy, quality, or clinical performance of independently supplied laboratory material.
Primary publications and technical references
- Randomized clinical trial, JAMA (2014) — view source
- Randomized clinical extension study (2010) — view source
Literature summaries are educational and refer only to the specific preparations and methods studied by the cited authors. These publications do not demonstrate that any APEP Biolabs material is suitable for human or veterinary use. Not medical advice. Laboratory research only. Do not administer or consume research materials.